Selected article for: "incubation period and virus contact"
Author: Muhammad Saqlain; Muhammad Muddasir Munir; Saif Ur Rehman; Aqsa Gulzar; Sahar Naz; Zaheer Ahmed; Azhar Hussain Tahir; Muhammad Mashhood
Title: Knowledge, attitude, practice and perceived barriers among healthcare professionals regarding COVID-19: A Cross-sectional survey from Pakistan
  • Document date: 2020_4_17
    • ID: 7rvv2kzk_3
    Snippet: COVID-19 transmits from person to person by droplets when an infected person sneezes and by direct contact and virus has an incubation period of 4-14 days [8] . Elderly and patients who suffered with chronic medical conditions like diabetes and cardiovascular diseases are more likely to get severe infection [8] . The main manifestations of COVID-19 are fever, dry cough, dyspnea, myalgia, fatigue, hypolymphaemia, and radiographic evidence of pneum.....
    Document: COVID-19 transmits from person to person by droplets when an infected person sneezes and by direct contact and virus has an incubation period of 4-14 days [8] . Elderly and patients who suffered with chronic medical conditions like diabetes and cardiovascular diseases are more likely to get severe infection [8] . The main manifestations of COVID-19 are fever, dry cough, dyspnea, myalgia, fatigue, hypolymphaemia, and radiographic evidence of pneumonia [1, 9] . Presently, no antiviral therapy or vaccine is explicitly recommended for COVID-19 and implementation of preventive measures to control COVID-19 is the mainstay critical intervention [10] . Amidst to current pandemic, WHO has issued several guidelines and also started online courses and training sessions to raise awareness and preparedness regarding prevention and control of . CC-BY 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • antiviral therapy and cardiovascular disease diabetes: 1, 2, 3, 4, 5, 6, 7, 8
    • antiviral therapy and cc international license: 1, 2, 3, 4, 5, 6, 7, 8
    • antiviral therapy and control prevention: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • antiviral therapy and current pandemic: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • antiviral therapy and direct contact: 1, 2, 3, 4, 5, 6
    • antiviral therapy and dry cough: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • antiviral therapy and incubation period: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • antiviral therapy and infected person: 1
    • antiviral therapy and international license: 1, 2, 3, 4, 5, 6, 7, 8
    • cardiovascular disease and cc international license: 1, 2, 3, 4, 5, 6, 7
    • cardiovascular disease and control prevention: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cardiovascular disease and critical intervention: 1, 2, 3
    • cardiovascular disease and current pandemic: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cardiovascular disease and direct contact: 1
    • cardiovascular disease and dry cough: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • cardiovascular disease and incubation period: 1, 2, 3, 4, 5, 6, 7
    • cardiovascular disease and infected person: 1
    • cardiovascular disease and international license: 1, 2, 3, 4, 5, 6, 7
    • cardiovascular disease diabetes and cc international license: 1, 2